library.onepin.app/ghk-cu Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Repair & Recovery

Repair & Recovery Endogenous copper-complexed tripeptide Not FDA-approved · investigational

GHK-Cu

Copper Peptide · Copper Tripeptide-1 · GHK Copper

Endogenous copper-complexed tripeptideExtracellular matrix remodeling peptideGene expression modulator (activates/suppresses approximately 4,000 human genes)Collagen synthesis activator via lysyl oxidase

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-complexed tripeptide found in human plasma, saliva, and urine. Plasma levels decline significantly with age, from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. GHK-Cu plays a central role in extracellular matrix remodeling, collagen synthesis, antioxidant defense, and gene expression regulation. It delivers copper to lysyl oxidase, the enzyme responsible for cross-linking collagen types I and III into durable, organized fibers. GHK-Cu is discussed in the context of skin rejuvenation, wound healing, tissue remodeling, hair growth support, and as a component of multi-peptide repair protocols (GLOW and KLOW blends). The copper ion is integral to its function but creates specific syringe mixing considerations.

Quick Start
Route
SubQ injection. Also available topically for skin applications.
Start low
1 to 2.5 mg daily
Frequency
Daily or 5 days on / 2 days off
Timing
No evidence-based fed or fasted requirement

Draw FIRST in multi-compound syringes (mechanical contamination prevention - copper transfer to needle hub can oxidize partner-vial peptides on later piercings). Inject immediately after drawing. Best administered in the evening/bedtime. No fasting required.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
1 to 2.5 mg daily · SubQ injection. Also available topically for skin applications. · Daily or 5 days on / 2 days off
Lowest starting point. Hold about a week to assess tolerance before stepping up.
1 to 2.5 mg daily
Daily or 5 days on / 2 days off
Standard
Systemic SubQ
1-2 mg · SubQ · Daily
anecdotal · community
1-2 mg
Daily
Standard
Topical Cosmetic
1-3% concentration · Topical · Daily
anecdotal · community
1-3% concentration
Daily
Reconstitution CalculatorU-100
050100u
Draw to
units
01

How it works

GHK-Cu delivers bioavailable copper(II) to lysyl oxidase and other copper-dependent enzymes critical for collagen cross-linking, elastin formation, and extracellular matrix integrity. Beyond its copper delivery role, GHK-Cu directly modulates gene expression, upregulating genes involved in tissue repair (collagen, decorin, metalloproteinases) while suppressing genes associated with inflammation and tissue destruction. It stimulates synthesis of collagen types I, III, and V, elastin, glycosaminoglycans, and proteoglycans. GHK-Cu also participates in redox homeostasis by regulating copper-dependent antioxidant enzymes (superoxide dismutase) and modulating iron metabolism. The tripeptide structure confers cell-penetrating ability, allowing intracellular gene expression effects beyond surface receptor signaling.

GHK-Cu delivers bioavailable copper(II) to lysyl oxidase and other copper-dependent enzymes critical for collagen cross-linking, elastin formation, and extracellular matrix integrity. Beyond its copper delivery role, GHK-Cu directly modulates gene expression, upregulating genes involved in tissue repair (collagen, decorin, metalloproteinases) while suppressing genes associated with inflammation and tissue destruction. It stimulates synthesis of collagen types I, III, and V, elastin, glycosaminoglycans, and proteoglycans. GHK-Cu also participates in redox homeostasis by regulating copper-dependent antioxidant enzymes (superoxide dismutase) and modulating iron metabolism. The tripeptide structure confers cell-penetrating ability, allowing intracellular gene expression effects beyond surface receptor signaling.

02

What to expect

Early
Days 1–7

Days 1-14: Minimal visible changes. GHK-Cu works through gene expression changes that take time to manifest in new protein synthesis. Injection tolerance is typically good.

Mid
Weeks 2–4

Weeks 2-6: Skin texture and firmness improvements begin to appear. Wound healing acceleration becomes noticeable if recovering from injury or procedure. Hair quality changes may begin.

Later
Weeks 4–12

Weeks 6-12: Cumulative collagen and elastin synthesis produces visible skin improvements. Tissue remodeling effects become apparent. Scar tissue softening reported. Best results at 8-12 weeks of consistent use.

03

Evidence

HumanModerate
AnimalPresent
In-vitroStrong
2018Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data · Pickart L, Margolina A, International Journal of Molecular Sciences ↗review
2015GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration · Pickart L, Vasquez-Soltero JM, Margolina A, BioMed Research International ↗review
2006Effects of Topical Copper Tripeptide Complex on CO2 Laser-Resurfaced Skin · Miller TR, Wagner JD, Baack BR, Eisbach KJ, Archives of Facial Plastic Surgery ↗peer reviewed
2012The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging · Pickart L, Vasquez-Soltero JM, Margolina A, Oxidative Medicine and Cellular Longevity ↗review
04

The honest take

Anti-aging / skin rejuvenation

Human topical studies support improvement in skin thickness, fine lines, and firmness. Gene expression data shows broad anti-aging gene activation. One of the better-supported anti-aging claims for any peptide, at least topically.

Hair growth

Animal and in vitro data show hair follicle enlargement and stem cell activation. Anecdotal human reports support this. Not a validated hair loss treatment.

Gene expression reset

Microarray studies show GHK-Cu modulates approximately 4,000 human genes, many toward a younger expression pattern. This is well-documented in vitro data. In vivo significance at injectable doses is extrapolated.

05

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

KPVKLOW blend synergy. GHK-Cu remodeling + KPV anti-inflammatory.
P-21Safe to mix. P-21 sequence (Ac-DGGLAG-NH2) has no methionine, tryptophan, or cysteine. No copper oxidation risk.
AOD-9604Non-overlapping mechanisms
SS-31GHK-Cu tissue + SS-31 mitochondrial

Keep separate

VIPCRITICAL: Copper ions catalyze oxidation of VIP's methionine-17 residue, destroying VIP's biological activity. NEVER mix in syringe or administer at the same injection site.
TB-500Full-length thymosin beta-4 (43aa) contains methionine at position 6, which is oxidized by Cu2+. The true TB-500 fragment (Ac-LKKTETQ, 7aa) has no oxidizable residues and would be safe, but most suppliers sell the full-length sequence. Keep on DO NOT MIX unless fragment version is confirmed via COA.
All BioregulatorsNo formal syringe compatibility data with GHK-Cu. These are short peptides (2-4 amino acids) with no Met/Trp/Cys. For draw-and-inject with GHK-Cu drawn LAST, copper contact is seconds and risk is negligible. Mixing only available if bioregulator mixing is enabled in settings.
CJC-1295 with DACDAC maleimide + copper = dual chemical reactivity risk.
06

Side effects & safety

Commonly reported

  • Mild injection site irritation (copper can cause local reaction)
  • Slight blue-green discoloration at injection site (temporary, from copper)
  • Generally very well tolerated systemically

Less common & notes

  • GHK-Cu is a naturally occurring human peptide with an excellent safety profile.
  • Copper overload is theoretically possible at very high doses but unlikely at standard peptide doses (total copper content per dose is micrograms).
  • Individuals with Wilson's disease or copper metabolism disorders should avoid.
  • Monitor copper and ceruloplasmin levels if using long-term at high doses.
07

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
0.5h
Peak · Tmax
0.05h
Elimination
2.5h
Activity
6-12 hours (gene expression changes persist well beyond peptide clearance)

Storage. Store unreconstituted vials frozen (-20C) or refrigerated (2-8C). After reconstitution, refrigerate at 2-8C. Stable for 28-30 days. Copper complex provides some structural stability. Solution may have slight blue tint (normal). Discard if cloudy or particles visible. Protect from light.

08

Regulatory status

GHK-Cu is available as a research peptide and through compounding pharmacies. Not FDA-approved for any indication. WADA status is not specifically addressed (unlikely to be tested for). Available in various topical cosmetic formulations without prescription.

Put it to work

Calculate, log & track

Open GHK-Cu straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open GHK-Cu in the app →

Go deeper

The guide & community

The complete GHK-Cu walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community